SCHEMBL4988076

SCHEMBL4988076

NC(=O)c1n[c]c2c(n1)CN(S(=O)(=O)c1ccccc1F)CC2

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
CHRNB2 P17787 2/20 0.42
CHRNB4 P30926 2/20 0.42
CHRNA3 P32297 2/20 0.42
CHRNA4 P43681 2/20 0.42
GAA P10253 1/20 0.40
TDP1 Q9NUW8 2/20 0.39
PKM P14618 3/20 0.38
RAB9A P51151 1/20 0.38
POLB P06746 1/20 0.38
ALDH1A1 P00352 3/20 0.37
MAPK1 P28482 2/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
KDM4E B2RXH2 1/20 0.37
GPR183 P32249 1/20 0.37
EPHX2 P34913 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4989380 0.89 ALDH1A1 (0.39) KMT2AL3MBTL1PKMALDH1A1
SCHEMBL4986273 0.89 PKM (0.42) KMT2AL3MBTL1PKMRAB9APOLB
SCHEMBL4986102 0.88 PKM (0.44) KMT2AL3MBTL1PKMPOLB
SCHEMBL4989326 0.88 ALDH1A1 (0.38) KMT2AL3MBTL1PKMPOLBALDH1A1
SCHEMBL4986044 0.87 FAAH (0.39) EPHX2
SCHEMBL4985355 0.87 EPHX2 (0.37) KMT2AL3MBTL1TDP1ALDH1A1MAPK1
SCHEMBL4989307 0.87 ALDH1A1 (0.46) KMT2AL3MBTL1GAAPKMRAB9A
SCHEMBL4991981 0.85 HCRTR1 (0.41) CHRNB2CHRNB4CHRNA3CHRNA4TDP1
SCHEMBL4992135 0.85 ATM (0.41) L3MBTL1GAATDP1PKMALDH1A1
SCHEMBL4988448 0.84 MEN1 (0.45) KMT2AGAAPKMALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080039478-A1 Bicycloheteroaryl Compounds as P2X7 Modulators and Uses Thereof RENOVIS, INC. 2008-02-14 US claimed
US-7297700-B2 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof RENOVIS, INC. (US) 2007-11-20 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080039478-A1 Bicycloheteroaryl Compounds as P2X7 Modulators and Uses Thereof P2RX7, P2RX3, P2RX2 KMT2A 4614/4885L3MBTL1 4476/4885CHRNB2 599/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.